MVA virus-based HCV vaccine (Helmholtz Zentrum Munchen/Ascenion)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMVA virus-based HCV vaccine (Helmholtz Zentrum Munchen/Ascenion)
Drug Alias Namemodified vaccinia Ankara virus-based HCV vaccine (Helmholtz Zentrum Munchen/Ascenion)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHelmholtz Zentrum Muenchen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelmholtz Zentrum MuenchenAscenion
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A